Implantable Cardiac Monitors in High-Risk Post-Infarction Patients With Cardiac Autonomic Dysfunction
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 400 participants.
Also called NCT02594488
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT02594488
-
- Other papers using this trial's data
- Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Germany
- Registry status
- Completed
Technical summary
Registry record NCT02594488. Randomized; no masking; primary purpose diagnostic. Start 2016-05-06 (actual); primary completion 2021-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Implantable Cardiac Monitors in High-Risk Post-Infarction Patients With Cardiac Autonomic Dysfunction
- Acronym
- SMART-MI
- Condition
- Myocardial Infarction
- Condition
- Autonomic Nervous System Diseases
- Intervention (Device)
- Medtronic Reveal LINQ implantable cardiac monitor
- Lead sponsor
- LMU Klinikum
- Collaborator
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Collaborator
- Medtronic Cardiac Rhythm and Heart Failure
Record details
- Record id
cardio:ct-nct02594488- Content hash
71568f56434fe6f5cecdd16a4c0e46ea63e86459b7f842c6029c8575ce2a1786